LAMEA COPD & Asthma Devices Market By Product Type (COPD & Asthma Inhaler - Dry Powder Inhalers, Metered Dose Inhalers, Soft Mist Inhalers; COPD & Asthma Nebulizer - Pneumatic Nebulizers, Ultrasonic Nebulizer, Mesh Nebulizer)

The LAMEA COPD & Asthma Device Market is expected to reach $ 6,951.1 Million by 2022 growing at a CAGR of 6.1% CAGR during 2016 - 2022. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions. However, the unknown etiology of asthma and COPD in medical industry may hamper the market growth in the next six years. Upcoming treatment methodologies such as once-a-day combination products and monoclonal antibodies have created new opportunities for the market growth. Additionally, pharmaceutical companies have been developing new bio-based medications in combination with bio-technology which promises immense growth opportunities along with sustainable development for asthma & COPD market over the next decade.

Click Here For Free Insights

The report highlights the adoption of COPD & Asthma Devices in LAMEA (Latin America, Middle East and Africa). Based on the product type; the market is segmented into Inhalers and Nebulizers market. Further the Inhaler segment is sub segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers Market.

The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria and Rest of LAMEA. Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

Related Reports:

Global COPD and Asthma Devices Market
 

Related Reports:

North America COPD and Asthma Devices Market

Europe COPD and Asthma Devices Market

Asia Pacific COPD and Asthma Devices Market

Global COPD and Asthma Devices Market

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA COPD & Asthma Devices, By Product Type
1.4.2 LAMEA COPD & Asthma Devices Market, By Country
1.5 Research Methodology
Chapter 2. LAMEA COPD and Asthma Devices Market Overview
2.1 Introduction
2.2 Key Influencing Factors
2.3 LAMEA COPD & Asthma Device Market
Chapter 3. LAMEA COPD and Asthma Device Market - By Product Type
3.1 LAMEA COPD & Asthma Inhaler Market
3.1.1 LAMEA COPD & Asthma Inhaler Market - By Product Type
3.1.1.1.1 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.1.2 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.1.3 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.1.1.2 LAMEA COPD & Asthma Inhaler Market
3.1.1.2.1 LAMEA COPD & Asthma Inhaler Market - By Country
3.1.1.2.2 LAMEA COPD & Asthma Dry Powder Inhalers (DPIs) Market
3.1.1.2.3 LAMEA COPD & Asthma Metered Dose Inhalers (MDIs) Market
3.1.1.2.4 LAMEA COPD & Asthma Soft Mist Inhalers (SMIs) Market
3.2 LAMEA COPD & Asthma Nebulizer Market
3.2.1 LAMEA COPD & Asthma Nebulizer Market - By Type
3.2.1.1.1 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.1.1.2 LAMEA COPD & Asthma Mesh Nebulizer Market - By Country
3.2.1.2 LAMEA COPD & Asthma Nebulizer Market - By Product Type
3.2.1.2.1 LAMEA COPD & Asthma Nebulizer Market - By Country
3.2.1.2.2 LAMEA COPD & Asthma Pneumatic Nebulizer Market
3.2.1.2.3 LAMEA COPD & Asthma Ultrasonic Nebulizer Market
3.2.1.2.4 LAMEA COPD & Asthma Mesh Nebulizer Market
Chapter 4. LAMEA COPD & Asthma Devices Market - By Country
4.1.1 Brazil COPD and Asthma Devices Market
4.1.1.1 Brazil COPD and Asthma Devices Market - By Product Type
4.1.1.1.1 Brazil COPD and Asthma Inhalers Market
4.1.1.1.2 Brazil COPD and Asthma Nebulizers Market
4.1.2 Argentina COPD and Asthma Devices Market
4.1.2.1 Argentina COPD and Asthma Devices Market - By Product Type
4.1.2.1.1 Argentina COPD and Asthma Inhalers Market
4.1.2.1.2 Argentina COPD and Asthma Nebulizers Market
4.1.3 UAE COPD and Asthma Devices Market
4.1.3.1 UAE COPD and Asthma Devices Market - By Product Type
4.1.3.1.1 UAE COPD and Asthma Inhalers Market
4.1.3.1.2 UAE COPD and Asthma Nebulizers Market
4.1.4 Saudi Arabia COPD and Asthma Devices Market
4.1.4.1 Saudi Arabia COPD and Asthma Devices Market - By Product Type
4.1.4.1.1 Saudi Arabia COPD and Asthma Inhalers Market
4.1.4.1.2 Saudi Arabia COPD and Asthma Nebulizers Market
4.1.5 South Africa COPD and Asthma Devices Market
4.1.5.1 South Africa COPD and Asthma Devices Market - By Product Type
4.1.5.1.1 South Africa COPD and Asthma Inhalers Market
4.1.5.1.2 South Africa COPD and Asthma Nebulizers Market
4.1.6 Nigeria COPD and Asthma Devices Market
4.1.6.1 Nigeria COPD and Asthma Devices Market - By Product Type
4.1.6.1.1 Nigeria COPD and Asthma Inhalers Market
4.1.6.1.2 Nigeria COPD and Asthma Nebulizers Market
4.1.7 Rest of LAMEA COPD and Asthma Devices Market
4.1.7.1 Rest of LAMEA COPD and Asthma Devices Market - By Product Type
4.1.7.1.1 Rest of LAMEA COPD and Asthma Inhalers Market
4.1.7.1.2 Rest of LAMEA COPD and Asthma Nebulizers Market
Chapter 5. Company Profiles
5.1 Glaxosmithcline PLC
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Segmental Analysis
5.1.4 Research & Development
5.2 Novartis International AG
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental Analysis
5.2.4 Research & Development
5.3 Merck & Co., Inc.
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental Analysis
5.3.4 Research & Development
5.4 AstraZeneca Plc
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental Analysis
5.4.4 Research & Development
5.5 3M Healthcare
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental Analysis
5.5.4 Research & Development
5.6 GF Health Products, Inc
5.6.1 Company Overview
5.7 Sunovion Pharmaceuticals Inc.
5.7.1 Company Overview
5.8 Smith Medicals, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.9 Baxter International
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental Analysis
5.9.4 Research & Development
5.1 Koninklijke Philips N.V.
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental Analysis
5.10.4 Research & Development

TABLE 1 LAMEA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 2 LAMEA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 3 LAMEA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 4 LAMEA COPD & ASTHMA DEVICE MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 5 LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 6 LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 7 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 8 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 9 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 10 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 11 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 12 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 13 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 14 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 15 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 16 LAMEA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 17 LAMEA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 18 LAMEA COPD AND ASTHMA INHALERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 19 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2012-2015
TABLE 20 LAMEA COPD AND ASTHMA DRY POWDER INHALERS (DPIS) MARKET ($ MILLION): 2016-2022
TABLE 21 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 22 LAMEA COPD AND ASTHMA METERED DOSE INHALERS (MDIS) MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 23 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 24 LAMEA COPD AND ASTHMA SOFT MIST INHALERS (SMIS) MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 25 LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY TYPE ($ MILLION): 2012-2015
TABLE 26 LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY TYPE ($ MILLION): 2016-2022
TABLE 27 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 28 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 29 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 30 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 31 LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 32 LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 33 LAMEA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2012-2015
TABLE 34 LAMEA COPD AND ASTHMA NEBULIZERS MARKET, BY COUNTRY ($ MILLION): 2016-2022
TABLE 35 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 36 LAMEA COPD AND ASTHMA PNEUMATIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 37 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 38 LAMEA COPD AND ASTHMA ULTRASONIC NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 39 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 40 LAMEA COPD AND ASTHMA MESH NEBULIZER MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 41 LAMEA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2012-2015
TABLE 42 LAMEA COPD & ASTHMA DEVICE MARKET, BY GEOGRAPHY ($ MILLION): 2016-2022
TABLE 43 BRAZIL COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 44 BRAZIL COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 45 BRAZIL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 46 BRAZIL COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 47 BRAZIL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 48 BRAZIL COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 49 BRAZIL COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 50 BRAZIL COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 51 ARGENTINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 52 ARGENTINA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 53 ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 54 ARGENTINA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 55 ARGENTINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 56 ARGENTINA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 57 ARGENTINA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 58 ARGENTINA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 59 UAE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 60 UAE COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 61 UAE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 62 UAE COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 63 UAE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 64 UAE COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 65 UAE COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 66 UAE COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 67 SAUDI ARABIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 68 SAUDI ARABIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 69 SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 70 SAUDI ARABIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 71 SAUDI ARABIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 72 SAUDI ARABIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 73 SAUDI ARABIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2012-2015
TABLE 74 SAUDI ARABIA COPD AND ASTHMA NEBULIZER MARKET ($ MILLION): 2016-2022
TABLE 75 SOUTH AFRICA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 76 SOUTH AFRICA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 77 SOUTH AFRICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 78 SOUTH AFRICA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 79 SOUTH AFRICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 80 SOUTH AFRICA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 81 SOUTH AFRICA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 82 SOUTH AFRICA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 83 NIGERIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2012-2015
TABLE 84 NIGERIA COPD & ASTHMA DEVICE MARKET ($ MILLION): 2016-2022
TABLE 85 NIGERIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 86 NIGERIA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 87 NIGERIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 88 NIGERIA COPD AND ASTHMA INHALERS MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 89 NIGERIA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 90 NIGERIA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 91 REST OF LAMEA COPD & ASTHMA DEVICE MARKET - BY COUNTRY ($ MILLION): 2012-2015
TABLE 92 REST OF LAMEA COPD & ASTHMA DEVICE MARKET - BY COUNTRY ($ MILLION): 2016-2022
TABLE 93 REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 94 REST OF LAMEA COPD AND ASTHMA DEVICES MARKET, BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 95 REST OF LAMEA COPD AND ASTHMA INHALERS MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 96 REST OF LAMEA COPD AND ASTHMA INHALERS MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 97 REST OF LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2012-2015
TABLE 98 REST OF LAMEA COPD AND ASTHMA NEBULIZER MARKET - BY PRODUCT TYPE ($ MILLION): 2016-2022
TABLE 99 KEY INFORMATION - GLAXOSMITHCLINE PLC.
TABLE 100 KEY INFORMATION - NOVARTIS INTERNATIONAL AG.
TABLE 101 KEY INFORMATION - BIOTRONIK SE & CO. KG.
TABLE 102 KEY INFORMATION - ASTRAZENECA PLC.
TABLE 103 KEY INFORMATION - 3M HEALTHCARE.
TABLE 104 KEY INFORMATION - GF HEALTH PRODUCTS, INC.
TABLE 105 KEY INFORMATION - SUNOVION PHARMACEUTICALS INC.
TABLE 106 KEY INFORMATION - SMITH MEDICALS, INC.
TABLE 107 KEY INFORMATION - BAXTER INTERNATIONAL.
TABLE 108 KEY INFORMATION - KONINKLIJKE PHILIPS N.V.